Improvements in devices and personal experience, the use of stents, and aggressive antiplatelet therapy have significantly reduced the incidence of major periprocedural complications PCI related over the past 15–20 years. Information drawn from almost 30 years of experience allows us to estimate the risk of complications according to patient and lesion characteristics; therefore, every physician needs to consider if the risk to benefit ratio of the planned procedure is appropriate on the basis of these data before performing any intervention. Complications that occur during PCI can be generally divided into three main groups: (A) cardiac-related complications, (B) vascular access-site-related complications, and (C) other complications (e.g., cholesterol embolism, contrast-induced nephropathy, thrombocytopenia, etc.).
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)